Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as an oral dosage form for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, erosive oesophagitis, peptic ulcer disease and is used in Helicobacter pylori eradication regimens.

GNH USA supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric proton pump to reduce acid secretion, making it useful for several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the esophageal lining. - Erosive oesophagitis: accelerates healing of erosive lesions in the esophagus. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication success.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools that may be transient. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of sickness without vomiting. - Flatulence: increased intestinal gas. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reactions: including anaphylaxis or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Liver enzyme elevation: signs of hepatic stress. - Hypomagnesemia: low magnesium levels with prolonged use. - Pancreatitis: inflammation of the pancreas. - Cardiac arrhythmias: irregular heart rhythms in susceptible individuals.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Avoid concomitant use with strong CYP2C19 inhibitors without medical supervision. - Use with caution in patients with hepatic impairment. - Discontinue if signs of severe allergic reaction appear. - Store at room temperature: keep in the original pack, protect from moisture and light.

Pantoprazole may interact with several medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: may reduce antiplatelet activity. - Atazanavir: decreased absorption leading to subtherapeutic levels. - Methotrexate: increased risk of toxicity.

Moderate Interactions (Monitor Closely): - Digoxin: possible increase in serum concentration. - Iron supplements: reduced absorption of iron when taken concurrently.